Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-33050184

RESUMO

The World Health Organization's Health Economic Assessment Tool (HEAT) for walking and cycling is a user-friendly web-based tool to assess the health impacts of active travel. HEAT, developed over 10 years ago, has been used by researchers, planners and policymakers alike in appraisals of walking and cycling policies at both national and more local scales. HEAT has undergone regular upgrades adopting the latest scientific evidence. This article presents the most recent upgrades of the tool. The health impacts of walking and/or cycling in a specified population are quantified in terms of premature deaths avoided (or caused). In addition to the calculation of benefits derived from physical activity, HEAT was recently expanded to include assessments of the burden associated with air pollution exposure and crash risks while walking or cycling. Further, the impacts on carbon emissions from mode shifts to active travel modes can now be assessed. The monetization of impacts using Value of Statistical Life and Social Costs of Carbon now uses country-specific values. As active travel inherently results in often substantial health benefits as well as not always negligible risks, assessments of active travel behavior or policies are incomplete without considering health implications. The recent developments of HEAT make it easier than ever to obtain ballpark estimates of health impacts and carbon emissions related to walking and cycling.


Assuntos
Ciclismo , Avaliação do Impacto na Saúde , Viagem , Caminhada , Poluição do Ar/análise , Poluição do Ar/economia , Avaliação do Impacto na Saúde/métodos , Humanos , Viagem/estatística & dados numéricos
2.
Int J Hyg Environ Health ; 218(6): 514-21, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26003939

RESUMO

BACKGROUND: There is growing evidence that chronic exposure to transportation related noise and air pollution affects human health. However, health burden to a country of these two pollutants have been rarely compared. AIMS: As an input for external cost quantification, we estimated the cardiorespiratory health burden from transportation related noise and air pollution in Switzerland, incorporating the most recent findings related to the health effects of noise. METHODS: Spatially resolved noise and air pollution models for the year 2010 were derived for road, rail and aircraft sources. Average day-evening-night sound level (Lden) and particulate matter (PM10) were selected as indicators, and population-weighted exposures derived by transportation source. Cause-specific exposure-response functions were derived from a meta-analysis for noise and literature review for PM10. Years of life lost (YLL) were calculated using life table methods; population attributable fraction was used for deriving attributable cases for hospitalisations, respiratory illnesses, visits to general practitioners and restricted activity days. RESULTS: The mean population weighted exposure above a threshold of 48dB(A) was 8.74dB(A), 1.89dB(A) and 0.37dB(A) for road, rail and aircraft noise. Corresponding mean exposure contributions were 4.4, 0.54, 0.12µg/m(3) for PM10. We estimated that in 2010 in Switzerland transportation caused 6000 and 14,000 YLL from noise and air pollution exposure, respectively. While there were a total of 8700 cardiorespiratory hospital days attributed to air pollution exposure, estimated burden due to noise alone amounted to 22,500 hospital days. CONCLUSIONS: YLL due to transportation related pollution in Switzerland is dominated by air pollution from road traffic, whereas consequences for morbidity and indicators of quality of life are dominated by noise. In terms of total external costs the burden of noise equals that of air pollution.


Assuntos
Poluição do Ar/efeitos adversos , Exposição Ambiental/efeitos adversos , Expectativa de Vida , Ruído dos Transportes/efeitos adversos , Meios de Transporte/estatística & dados numéricos , Poluição do Ar/economia , Doenças Cardiovasculares/economia , Doenças Cardiovasculares/etiologia , Efeitos Psicossociais da Doença , Humanos , Modelos Teóricos , Ruído dos Transportes/economia , Material Particulado/toxicidade , Qualidade de Vida , Medição de Risco/estatística & dados numéricos , Suíça/epidemiologia , Meios de Transporte/métodos
3.
Eur J Public Health ; 21(3): 316-22, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20929904

RESUMO

BACKGROUND: Introducing comprehensive smoke-free policies to public places is expected to reduce health costs. This includes prevented health damages by avoiding environmental tobacco smoke (ETS) exposure as well as indirect health benefits from reduced tobacco consumption. METHODS: The aim of this study was to estimate direct health costs of ETS exposure in public places and indirect health benefits from reduced tobacco consumption. We calculated attributable hospital days and years of life lost (YLL), based on the observed passive smoking and disease rates in Switzerland. The exposure-response associations of all relevant health outcomes were derived by meta-analysis from prospective cohort studies in order to calculate the direct health costs. To assess the indirect health benefits, a meta-analysis of smoking ban studies on hospital admissions for acute myocardial infarction was conducted. RESULTS: ETS exposure in public places in Switzerland causes 32,000 preventable hospital days (95% CI: 10,000-61,000), 3000 YLL (95% CI: 1000-5000), corresponding to health costs of 330 Mio CHF. The number of hospital days for ischaemic heart disease attributable to passive smoking is much larger if derived from smoking ban studies (41,000) than from prospective cohort studies (3200), resulting in additional health costs of 89 Mio CHF, which are attributed to the indirect health benefits of a smoking ban introduction. CONCLUSION: The example of smoking ban studies on ischaemic heart disease hospitalization rates suggests that total health costs that can be prevented with smoking bans are considerably larger than the costs arising from the direct health impact of ETS exposure in public places.


Assuntos
Custos de Cuidados de Saúde/estatística & dados numéricos , Abandono do Hábito de Fumar/economia , Fumar/legislação & jurisprudência , Poluição por Fumaça de Tabaco/economia , Poluição por Fumaça de Tabaco/prevenção & controle , Adolescente , Adulto , Idoso , Estudos de Coortes , Exposição Ambiental/efeitos adversos , Política de Saúde , Humanos , Expectativa de Vida , Neoplasias Pulmonares/economia , Neoplasias Pulmonares/etiologia , Neoplasias Pulmonares/prevenção & controle , Pessoa de Meia-Idade , Isquemia Miocárdica/economia , Isquemia Miocárdica/etiologia , Isquemia Miocárdica/prevenção & controle , Estudos Prospectivos , Suíça , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA